Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Psyched Wellness Ltd (OP: PSYCF ) 0.0299 +0.0020 (+7.17%) Streaming Delayed Price Updated: 10:34 AM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Psyched Wellness Ltd Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More September 05, 2023 Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Via Benzinga EXCLUSIVE: Psychedelics Co. Closes $7.5M Financing - Here's Its Secret To Raising Millions In A Tough Environment September 01, 2023 In the bustling heart of Miami, amidst the buzz of the Benzinga Cannabis and Psychedelics Capital Conference, a pivotal conversation ignited a partnership destined to revolutionize the world of... Via Benzinga Topics Cannabis Exposures Cannabis Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More May 15, 2023 Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths... Via Benzinga Amanita Muscaria Mushrooms Are Taking The Lead In Markets As Research Ramps Up May 04, 2023 Amanita Muscaria is the only kind of mushroom currently legal. As its health benefits are regularly being confirmed in studies, demand for related products is rapidly growing. Via Benzinga Amanita Muscaria: A Legal Psychoactive Mushroom With Potential Therapeutic Effects April 22, 2021 Amanita Muscaria is an understudied species of psychoactive mushroom that’s as commonplace as it is misunderstood. The iconic red-c... Via Benzinga Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation February 16, 2023 Delix Nabs 2 New Partners Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience. The goal is to expedite Delix's drug... Via Benzinga Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce January 24, 2023 Health Canada Oks Clinical-Grade MDMA Export To UK Life sciences psychedelics company PharmAla Biotech Holdings Inc. and its manufacturing partners received a Health Canada export permit for no less... Via Benzinga Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States November 03, 2022 Canadian-based producer of mushroom-derived health supplements Psyched Wellness Ltd. Via Benzinga Amanita Muscaria Mushroom-Based Products Now Offered Online By Psyched Wellness June 15, 2022 Canadian life sciences company Psyched Wellness Ltd. Via Benzinga Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved April 25, 2022 Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... Via Benzinga Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage April 25, 2022 Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... Via Benzinga EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle April 19, 2022 Psyched Wellness Ltd (OTCQB: PSYCF) plans to begin selling a psychoactive mushroom extract this summer that’s never been scheduled as a drug in the U.S. Via Benzinga Psyched Wellness CEO Buys This Many Shares In The Open Market April 19, 2022 Jeffrey Stevens, the CEO and co-founder of Psyched Wellness (OTCQB: PSYCF), has bought 321,000 shares of the company in the open market at CA$0.125 per share for a total cost of of CA$40,125 (around... Via Benzinga Core One Labs Begins Trading On OTCQB April 06, 2022 Under the CLABF symbol, psychedelics-oriented company Core One Labs (OTCQB: CLABF) started trading on the OTCQB Venture ... Via Benzinga Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 The Week In Psychedelics Via Benzinga There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.